Reaction
Central Venous Catheter Removal reporting signals
As of the last recalculation, Central Venous Catheter Removal appears in 466 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is EPOPROSTENOL (PRR 78.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Epoprostenol | 22 | 78.7 | 78.9 |
| Niraparib | 25 | 53.1 | 53.2 |
| Emicizumab | 7 | 25.7 | 25.7 |
| Agalsidase Beta | 5 | 24.4 | 24.4 |
| Riociguat | 14 | 19.7 | 19.7 |
| Ivacaftor | 3 | 17.0 | 17.0 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 4 | 14.4 | 14.4 |
| Voxelotor | 7 | 14.1 | 14.1 |
| Ambrisentan | 36 | 13.9 | 13.9 |